drugset / Trial / NCT00568074
Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Asia. The aim of this trial is to compare the efficacy and safety of repaglinide and Glurenorm® and Glucobay® given as the mono-therapy in Chinese subjects being treatment-naive type 2 diabetics.
Timeline
- Start
- 2003-12-16
- Primary completion
- 2004-09-02
- Completion
- 2004-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acarbose | Unknown | — | — |
| Subject | GLIQUIDONE | Small molecule | — | — |
| Subject | Repaglinide | Small molecule | — | — |